Defining the spectrum of sickle cell disease in East Africa: a clinico- epidemiological study. (360G-Wellcome-072064_B_03_Z)
Much of what is known about the clinical picture, natural history and effective interventions in sickle cell disease (SCD) is based on long-term research programmes in Jamaica and USA. There are limited prospective systematic studies done in Africa, which is remarkable considering that over 90% of SCD patients are in Africa, but less than 2% of SCD born survive to adulthood. There is every reason to expect that improvements in morbidity and mortality similar to those elsewhere could be achieved in Africa but limitations of resources mean that it is essential that proposed interventions be based on a clear definition of the problems. Since April 2002, I have been attached to the KEMRI Wellcome collaborative programme in Kilifi (CGMR-C) and have established a baseline for this proposal by reviewing and reorganising the SCD clinical services in Muhimbili National Hospital (MNH), Dar-es-Salaam, Tanzania. Secondly I conducted pilot studies in MNH and CGMR-C to measure the range of cerebral blood flow velocities (CBFv) using Transcranial Doppler ultrasonography (TCD) in large intracranial arteries in SCD-SS and identify the ones with high risk of cerebral infarcts. In this proposal, I plan to describe the clinical spectrum of SCD in E. Africa by defining the major causes of morbidity and mortality. I will focus on questions on malaria, bacterial infections and stroke, in order to establish clear answers relevant to determining treatment guidelines. The second component, carried out at MNH and CGMR-C, will follow up SCD patients to evaluate the outcome, particularly stroke in relation to increased CBFv detected by TCD in this setting. This proposal, with subsequent establishment of a birth cohort, will attempt to establish a systematic framework for prospective, natural history studies which will allow better understanding of the molecular and genetic mechanisms determining disease severity in Africa.
Where is this data from?
This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.
Grant Details
| Region | International |
| Award Date | 2003-02-05T00:00:00+00:00 |
| Sponsor(s) | Prof Kevin Marsh, Prof K Pallangyo |
| Internal ID | 072064/B/03/Z |
| Planned Dates: End Date | 2007-09-30T00:00:00+00:00 |
| Planned Dates: Start Date | 2003-10-01T00:00:00+00:00 |
| Amount Awarded | 159316 |
| Financial Year | 2002/03 |
| Lead Applicant | Prof Julie Makani |
| Grant Programme: Title | Training F'ships - Trop/Dev Countries |
| Applicant Surname | Makani |
| Approval Committee | Tropical Interest Group |
| Recipient Org: Country | Tanzania |
| Recipient Org: City | Dar es Salaam |
| Has the grant transferred? | No |
| Research conducted at multiple locations? | Yes |
| Total amount including partnership funding | 159316 |